Lumify Reaches Canada As Consumer Health Leads Sales In Bausch + Lomb's Debut Quarter

Lumify sales grew reported 21% to brand-record $35m in Q2, Bausch + Lomb’s first quarter since separating from Bausch Health through an IPO in May.

• Source: Alamy

The Lumify brand debuted when its marketer launched as Bausch Health Companies Inc. and four years later sales of the OTC eye drops were key in the debut of manufacturer Bausch + Lomb Corp. as a standalone company.

Lumify (brimonidine tartrate 0.025%) sales grew a reported 21% on an increase in demand to a brand-record $35m in the...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Archive

More from HBW Insight